Back

Open Heart

18 training papers 2019-06-25 – 2026-03-07

Top medRxiv preprints most likely to be published in this journal, ranked by match strength.

1
The Effect of Zalunfiban on High Sensitivity Cardiac Troponin and the Association with Clinical Outcomes in Patients with STEMI
2026-02-09 cardiovascular medicine 10.64898/2026.02.03.26345522
#1 (9.5%)
Show abstract

BackgroundAmong patients with ST segment elevation myocardial infarction (STEMI), higher concentrations of high sensitivity troponin T (hs-cTnT) are associated with larger MI size and predict a worse prognosis. In the 2467 patient CELEBRATE trial, a single subcutaneous injection of the short-acting glycoprotein IIb/IIIa receptor blocker antagonist zalunfiban at first medical contact significantly improved the primary outcome including clinical endpoints. In this study, we assessed the impact of ...

2
Antithrombotic Therapy in Atrial Fibrillation Patients with Prior Complex Percutaneous Coronary Intervention: A Secondary Analysis of the Randomized ADAPT AF-DES Trial
2026-03-03 cardiovascular medicine 10.64898/2026.02.26.26347227
#1 (7.8%)
Show abstract

BackgroundIn patients with atrial fibrillation (AF) and stable coronary artery disease beyond 1 year after percutaneous coronary intervention (PCI), oral anticoagulant monotherapy is guideline-recommended; however, its efficacy and safety in patients with complex PCI remain uncertain. MethodsWe conducted a post-hoc analysis of the randomized ADAPT AF-DES trial comparing NOAC monotherapy versus NOAC plus clopidogrel in AF patients [≥]12 months after second- or third-generation drug-eluting st...

3
SOLO study: A single-pill combination strategy in general practice to optimize blood pressure control in a multi-ethnic community
2026-02-26 cardiovascular medicine 10.64898/2026.02.24.26346976
Top 0.1% (6.9%)
Show abstract

BackgroundHypertension is a major modifiable risk factor for cardiovascular disease, yet blood pressure (BP) control remain suboptimal, particularly in socially disadvantaged communities. Guidelines recommend initiating single-pill combination (SPC) therapy to improve adherence and BP control, but uptake in primary care is limited. ObjectivesTo evaluate the SOLO care improvement project, promoting SPC initiation among general practitioners (GPs) in Amsterdam Zuidoost, a disadvantaged, multi-eth...

4
Multimodal Assessment of Atrial Cardiomyopathy Identifies a High-Risk Subgroup of Embolic Stroke of Undetermined Source
2026-02-10 cardiovascular medicine 10.64898/2026.02.06.26345789
Top 0.1% (6.9%)
Show abstract

BackgroundEmbolic stroke of undetermined source (ESUS) is associated with a high risk of recurrence. However, randomized trials have not shown superiority of anticoagulation over aspirin in unselected patients. Atrial cardiomyopathy (AtCM) may identify a high-risk ESUS phenotype. We investigated whether multimodal AtCM markers distinguish ESUS from controls and predict adverse clinical outcomes. MethodsIn this prospective single-center study, consecutive ESUS patients and age- and sex-matched c...

5
Validation of the ESC 0/3h-Algorithm with a Novel High-Sensitivity Cardiac Troponin I Assay in Patients with Suspected Myocardial Infarction
2026-02-24 emergency medicine 10.64898/2026.02.10.26346042
Top 0.1% (6.7%)
Show abstract

BackgroundThere is uncertainty among physicians regarding the optimal clinical application of the novel high-sensitivity cardiac troponin I (hs-cTnI)-VITROS assay within the widely implemented upper reference limit (URL)-based ESC 0/3h-algorithm. MethodsThis prospective, international, multicenter study aimed to validate and compare different modifications of the URL-based ESC 0/3h-algorithm among adult patients presenting with suspected acute myocardial infarction (AMI) to the emergency depart...

6
Insulin-like Growth Factor-Binding Protein 2 and Adverse Left Ventricular Remodeling After First Myocardial Infarction
2026-03-05 cardiovascular medicine 10.64898/2026.03.04.26347626
Top 0.3% (6.4%)
Show abstract

Background and AimsDespite advances in reperfusion and medical therapy, survivors of acute myocardial infarction (AMI) remain at risk for adverse left ventricular remodeling (LVR), a precursor to heart failure. Building on prior work outlining 12-month biomarker trajectories linked to early ventricular dysfunction, we aimed to assess whether these circulating biomarkers predict long-term adverse LVR. MethodsWe prospectively enrolled 155 patients experiencing their first AMI. Clinical, biochemic...

7
Remote Patient Monitoring in Heart Failure: Firm Evidence for Mortality Reduction and a Critical Geographic Evidence Gap - Systematic Review, Meta-Analysis, and Trial Sequential Analysis
2026-02-27 cardiovascular medicine 10.64898/2026.02.25.26347143
Top 0.3% (6.4%)
Show abstract

Whether the cumulative evidence for remote patient monitoring (RPM) in heart failure (HF) has reached a definitive threshold -- and whether benefits extend to geographically underserved populations -- remains uncertain. We conducted a systematic review, meta-analysis, and trial sequential analysis (TSA) of 65 RCTs (59 poolable; [~]23,000 participants) across four databases through February 2026, encompassing structured telephone support (15 trials), non-invasive telemonitoring (33), and invasive...

8
Conversational artificial intelligence HeAlth supporT in Atrial Fibrillation Self-Management (CHAT-AF-S): rationale and randomised controlled trial design
2026-03-03 cardiovascular medicine 10.64898/2026.03.02.26347433
Top 0.3% (6.4%)
Show abstract

IntroductionAtrial fibrillation (AF), a common arrhythmia, is associated with impaired quality of life (QoL) and increased stroke risk and mortality. Clinical guidelines recommend leveraging digital technologies to support patient education and AF self-management. Conversational artificial intelligence (AI) technologies may support patient engagement with self-management by enabling human-like conversations. This study aims to evaluate the effectiveness of a conversational AI intervention (Conve...

9
Get With The Guidelines-Heart Failure Hospital Participation and its Association with Guideline-Directed Medical Therapy and Outcomes
2026-03-04 cardiovascular medicine 10.64898/2026.03.03.26347559
Top 0.5% (6.1%)
Show abstract

PurposeDespite strong evidence, real-world adoption of guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) remains suboptimal. The Get With The Guidelines-Heart Failure (GWTG-HF) program was designed to close gaps in care. We evaluated whether hospital participation in GWTG-HF is associated with greater GDMT intensity and improved outcomes. MethodsWe conducted a retrospective analysis (2013-2021) of Medicare beneficiaries with Part A and Part D hos...

10
The minimum number of blood pressure measurements needed and thresholds for visit-to-visit blood pressure variability to predict cardiovascular disease in primary care patients
2026-03-04 cardiovascular medicine 10.64898/2026.03.02.26347458
Top 0.6% (5.9%)
Show abstract

ObjectivesVisit-to-visit blood pressure variability (VVV BPV) is an underutilised risk factor for cardiovascular disease (CVD). This study aims to determine the minimum number of BP measurements needed and to identify cut-off values for the standard deviation (SD), coefficient of variation (CV), and average real variability (ARV) of systolic and diastolic VVV BPV to predict CVD risk in primary care. MethodsWe analysed data from the electronic practice-based research network (ePBRN) in Southwest...

11
Predictors of statin adherence in primary care using real-world data
2026-02-26 cardiovascular medicine 10.64898/2026.02.24.26347032
Top 0.7% (5.8%)
Show abstract

PurposeThe objective of this study was to identify predictors of statin adherence in the primary and secondary prevention of CVD among patients in the first two years after the date of first prescription using real-world data. MethodsThe Electronic Practice Based Research Network Linked Dataset was used in this study. Statin adherence was calculated using a modified proportion of days covered (PDC) formula. Individuals with PDC [≥] 80% during the two years of observation period were consider...

12
Predictors of statin intolerance in primary care using real-world data
2026-02-24 cardiovascular medicine 10.64898/2026.02.23.26346866
Top 0.7% (5.7%)
Show abstract

ObjectiveThe objective of this study was to explore the predictors of statin intolerance in the primary and secondary prevention of CVD among patients in the first two years after the date of first prescription using real-world data. MethodsThis study used the Electronic Practice Based Research Network Linked Dataset. An algorithm, which considered the muscle symptoms and creatinine kinase of patients, was used to identify statin intolerant patients. The R software was used for all analyses. De...

13
Ketone-Based Therapies in Adults Heart Failure: A Systematic Review and Quantitative Analysis
2026-03-05 cardiovascular medicine 10.64898/2026.03.04.26347628
Top 0.8% (5.7%)
Show abstract

BackgroundKetone bodies have shown potential to improve cardiac metabolism and function in patients with heart failure (HF). ObjectiveTo evaluate the effects of exogenous ketone-based interventions on cardiac function in patients with HF or related cardiometabolic risk factors. MethodsWe conducted a systematic review based on a search of MEDLINE, EMBASE, CINAHL, Cochrane Library, and Scopus from inception to January 2025. Eligible studies included randomized controlled trials evaluating exogen...

14
Cardiovascular Outcomes with α1 Adrenergic Receptor Antagonists vs 5α-Reductase Inhibitors
2026-02-25 cardiovascular medicine 10.64898/2026.02.23.26346940
Top 0.9% (5.3%)
Show abstract

Background-Blockers (ABs) are the most commonly prescribed medications for benign prostatic hyperplasia (BPH), a highly prevalent condition. Although the ALLHAT raised concerns about cardiovascular (CV) safety of nonselective ABs for the treatment of hypertension, the comparative CV risk profile of selective 1A-adrenergic receptor (1A-AR) antagonists for BPH remains unclear. MethodsWe conducted a retrospective cohort study using the TriNetX federated research network (158 million patients acros...

15
Validation of case correctness and time intervals agreement in the Swedish registry of cardiopulmonary resuscitation using emergency medical dispatch data, 2015-2024
2026-02-23 cardiovascular medicine 10.64898/2026.02.20.26346753
Top 1% (5.1%)
Show abstract

ObjectiveTo validate case number correctness and time interval agreement in the Swedish Registry of Cardiopulmonary Resuscitation (SRCR) for out-of-hospital cardiac arrest (OHCA) by linkage to Emergency Medical Dispatch Centre (EMDC) data between 2015 and 2024. MethodsIn this retrospective validation study, OHCA records reported to the SCRC were linked with EMDC-indexed OHCA for validation and correction of EMS case numbers. We quantified the proportion of correct EMS case numbers reported as a...

16
Infective Endocarditis Prophylaxis Practices in Pediatric and Congenital Patients with Cardiac Implantable Electronic Devices: An International PACES Survey
2026-02-09 cardiovascular medicine 10.64898/2026.02.05.26345706
Top 1% (5.0%)
Show abstract

Structured AbstractO_ST_ABSBackgroundC_ST_ABSGuideline recommendations for infective endocarditis (IE) prophylaxis have narrowed significantly over the past decade. However, these recommendations are derived from adult data and may not adequately account for the unique risk factors for IE in pediatric and congenital heart disease (CHD) patients with cardiac implantable electronic devices (CIEDs). ObjectiveTo characterize contemporary IE cases and prophylaxis practices among members of the Pedia...

17
Glucagon-Like Peptide-1 Receptor Agonists Across the Heart Failure Spectrum: A Systematic Review and Meta-Analysis
2026-02-11 cardiovascular medicine 10.64898/2026.02.10.26345946
Top 1% (5.0%)
Show abstract

We performed a systematic review and meta-analysis of randomized controlled trials evaluating glucagon-like peptide-1 receptor agonists (GLP-1 RAs) versus placebo in adults with heart failure (HF), searching PubMed, Cochrane CENTRAL, and ClinicalTrials.gov through February 2026. The primary outcome was the composite of cardiovascular death and first HF hospitalization. Random-effects meta-analysis used restricted maximum likelihood estimation with Hartung-Knapp-Sidik-Jonkman adjustment. We inclu...

18
Interventions to manage intolerance among patients prescribed statins for primary prevention of cardiovascular diseases: A systematic review and meta-analysis
2026-02-24 cardiovascular medicine 10.64898/2026.02.23.26346865
Top 1% (5.0%)
Show abstract

The objective of this systematic review and meta-analysis was to identify the interventions used to manage intolerance in patients receiving statins for primary prevention of CVD and to determine the effectiveness of these interventions. This study was conducted according to the PRISMA checklist. The electronic databases MEDLINE (PubMed), SCOPUS, EMBASE, and CINAHL were searched for studies published until June 2025. Based on the NLA definition of statin intolerance, the outcomes were split into...

19
Anatomical Accuracy of Generative AI for Congenital Heart Disease Illustrations: Gemini NanoBanana Versus ChatGPT Models in a Blinded Comparative Study
2026-02-23 cardiovascular medicine 10.64898/2026.02.21.26346792
Top 1% (4.9%)
Show abstract

BackgroundGenerative artificial intelligence (AI) systems are increasingly used to produce medical illustrations for education; however, their anatomical accuracy in complex domains such as congenital heart disease (CHD) remains insufficiently validated. MethodsIn an assessor-blinded comparative study, we evaluated AI-generated CHD illustrations from two contemporary text-to-image platforms (ChatGPT-5/ChatGPT-Images and Gemini NanoBanana) against human-modified educational images. Twenty differ...

20
Effectiveness and Safety of Bempedoic Acid in Taiwanese Patients with Hypercholesterolemia - A Pragmatic Phase IV Study (CLEAR Taiwan Study)
2026-02-09 cardiovascular medicine 10.64898/2026.02.06.26345788
Top 1% (4.9%)
Show abstract

BackgroundElevated low-density lipoprotein cholesterol (LDL-C) is a risk factor for cardiovascular disease. Despite available lipid-lowering therapies (LLT), lipid control remains suboptimal. Bempedoic acid offers a non-statin oral treatment for hypercholesterolemia. However, real-world data in Asia are limited. The study aimed to investigate the effectiveness and safety of bempedoic acid in Taiwan. MethodsThis pragmatic phase IV study enrolled 180 patients with inadequately controlled hypercho...